Varda
varda.com/Platform for Pharmaceutical Drug manufacturing in space.
Price per share
12M · USD
Funding history
$M raised · $B post-money
Signals
2 latest
Varda Space Industries Successfully Reenters W-6
Varda Space Industries, the leader in orbital pharmaceutical processing and hypersonic reentry, announced the successful reentry of its W-6 capsule. The capsule landed safely within the designated recovery zone at the Koonibba Test Range in South Australia, operated by Southern Launch, marking the company's second reentry of 2026.Similar to Varda's previous missions with Department of War payloads, the W-6 mission was funded through the Prometheus program, a partnership between the Air Force Research Laboratory (AFRL) and commercial space entities, which is addressing a national security need to accelerate novel science and technology experiments in the extreme hypersonic reentry environment through a low-cost, high-cadence flight testbed.
Source: PRnewswire
Varda Space Industries and United Therapeutics Collaborate to Advance Microgravity-Enabled Treatments for Rare Pulmonary Disease
Varda Space Industries today announced a collaboration with United Therapeutics Corporation (Nasdaq: UTHR) to explore the use of microgravity to develop improved formulations of treatments for rare pulmonary disease.Through the collaboration, Varda and United Therapeutics will conduct pharmaceutical processing of small molecule medicines for pulmonary disease aboard Varda's orbital manufacturing and reentry platform during multiple missions to low Earth orbit.
Source: PRnewsWire